Related Experiment Video
Updated: Jan 15, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.6K
Posterior Reversible Encephalopathy Syndrome as an Unusual Complication of Routine Chemotherapy: A Case Report
Ahmed Osman1, Maximilian Bonnici1, Samruddhi Jain1
1Radiology, St. Vincent Hospital, Worcester, USA.
Cureus
|January 14, 2026
Summary
Posterior reversible encephalopathy syndrome (PRES) can be induced by chemotherapy, specifically gemcitabine. Early recognition and management of PRES are crucial to prevent permanent neurological damage.
Area of Science:
- Neurology
- Oncology
- Radiology
Background:
- Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder.
- Chemotherapy, particularly gemcitabine, is increasingly implicated in PRES induction.
- The exact mechanism of gemcitabine-induced PRES, likely involving endothelial dysfunction and vasogenic edema, remains poorly understood.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
574
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
574
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
802
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
802
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
595
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
595